Precipitate formed by thiopentone and vecuronium causes pulmonary embolism

Canadian Journal of Anaesthesia

Volumn 45, Issue 4, 1998, Pages 347-351

  Taniguchi, Takumi ^a   Yamamoto, Ken ^a   Kobayashi, Tsutomu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THIOPENTAL; VECURONIUM;

ANESTHESIA COMPLICATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; HISTOLOGY; LUNG EMBOLISM; NONHUMAN; OXYGEN TENSION; PRECIPITATION; PRIORITY JOURNAL; RABBIT;

EID: 0031858599     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03012027     Document Type: Article

References (12)

1. Taniguchi T, Yamamoto K, Kobayashi T. The precipitate formed by thiopentone and vecuronium. Can J Anaesth 1996; 43: 511-3.
2. Blackman GL, Jordan GJ. Analysis of thiopentone in human plasma by high-performance liquid chromatography. J Chromatogr 1978; 145: 492-5.
3. Hull CJ. General principles of pharmacokinetics. In: Prys-Roberts C, Hug CC Jr (Eds.). Pharmacokinetics of Anaesthesia. Oxford: Blackwell Scientific Publications, 1984: 1-24.
4. Rowland M, Tozer TN. Clinical Pharmacokinetics. Concepts and Applications, 3rd ed. Philadelphia: Lea & Febiger, 1995: 469-89.
5. Collins JL, Lutz RJ. In vitro study of simultaneous infusion of incompatible drugs in multilumen catheters. Heart Lung 1991; 20: 271-7.
6. Allen LV Jr, Levinson RS, Phisutsinthop D, Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am J Hosp Pharm 1977; 34: 939-43.
7. Lutz RJ, Dedrick RL, Boretos JW, Oldfield EH, Blacklock JB, Doppman JL. Mixing studies during intracarotid artery infusions in an in vitro model. J Neurosurg 1986; 64: 277-83.
8. TarrBD, Yalkowsky SH. A new parenteral vehicle for the administration of some poorly water soluble anticancer drugs. J Parenter Sci Technol 1987; 41: 31-3.
9. Yalkowsky SH, Valvani SC, Johnson BW. In vitro method for detecting precipitation of parenteral formations after injection. J Pharm Sci 1983; 72: 1014-7.
10. Schroeder HG DeLuca PP. Particulate matter assessment of a clinical investigation on filtration and infusion phlebitis. Am J Hosp Pharm 1976; 33: 543-6.
11. Flynn GL. Solubility concepts and their applications to the formulation of pharmaceutical systems. J Parenter Sci Technol 1984; 38: 202-9.
12. Benumof JL. Respiratory physiology and respiratory function during anesthesia. In: Miller RD (Ed.). Anesthesia, 4th ed. New York: Churchill Livingstone, 1994: 594-600.